PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Estatística, Análise Matemática e Optimizacióngl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéuticagl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Zooloxía e Antropoloxía Físicagl
dc.contributor.authorGarcía Otero, Xurxo
dc.contributor.authorMondelo García, Cristina
dc.contributor.authorBandín Vilar, Enrique
dc.contributor.authorGómez Lado, Noemí
dc.contributor.authorSilva Rodríguez, Jesús
dc.contributor.authorRey Bretal, David
dc.contributor.authorOtero Espinar, María Victoria
dc.contributor.authorAdán Civera, Alfredo
dc.contributor.authorGonzález Barcia, Miguel
dc.contributor.authorFernández Ferreiro, Anxo
dc.contributor.authorAguiar Fernández, Pablo
dc.contributor.authorOtero Espinar, Francisco Javier
dc.contributor.authorFernández Ferreiro, Anxo
dc.date.accessioned2022-11-09T09:09:36Z
dc.date.available2022-11-09T09:09:36Z
dc.date.issued2022
dc.description.peerreviewedSIgl
dc.description.sponsorshipX. García-Otero is grateful to the IDIS (Health Research Institute of Santiago de Compostela) for financing his predoctoral research fellowship. C. Mondelo-García, E. Bandín-Vilar and A. Fernández-Ferreiro are grateful to the Carlos III Health Institute for financing their personnel contracts: JR20/00026, CM20/00135 and JR18/00014.gl
dc.identifier.citationInternational Journal of Pharmaceutics 627 (2022) 122261gl
dc.identifier.doi10.1016/j.ijpharm.2022.122261
dc.identifier.essn0378-5173
dc.identifier.urihttp://hdl.handle.net/10347/29388
dc.language.isoenggl
dc.publisherElseviergl
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijpharm.2022.122261gl
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen accessgl
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdalimumabgl
dc.subjectAnti-TNFαgl
dc.subjectPharmacokineticsgl
dc.subjectMolecular imaginggl
dc.subjectPositrongl
dc.subjectEmission Tomographygl
dc.subjectEndotoxin-induced uveitisgl
dc.titlePET study of intravitreal adalimumab pharmacokinetics in a uveitis rat modelgl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublicationf0a02245-3bba-4bfb-8172-5f0e3b2f20fe
relation.isAuthorOfPublicationb2cecd5d-4c3a-4dee-9c57-e890482e3031
relation.isAuthorOfPublication2110b154-c3b5-463d-a7fa-78d2370a8b43
relation.isAuthorOfPublication6a1630c3-8a68-4656-9fac-695b76a69303
relation.isAuthorOfPublicatione1eb8f2f-9516-4a0f-8819-2cad31053b62
relation.isAuthorOfPublication.latestForDiscoveryf0a02245-3bba-4bfb-8172-5f0e3b2f20fe

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022_intjpharm_garcia_pet.pdf
Size:
3.63 MB
Format:
Adobe Portable Document Format
Description:
Artigo de investigación